Secondary Immunodeficiency (SID)Symptoms, Doctors, Treatments, Advances & More
Learn About Secondary Immunodeficiency (SID)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Heart And Vascular Center At Durham Outpatient Center
Heather Strah is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Omaha, Nebraska. She has been practicing medicine for over 19 years. Dr. Strah is rated as a Distinguished provider by MediFind in the treatment of Secondary Immunodeficiency (SID). She is also highly rated in 10 other conditions, according to our data. Her clinical expertise encompasses Hypersensitivity Pneumonitis, Secondary Immunodeficiency (SID), Acute Interstitial Pneumonia, Lung Transplant, and Advanced Bronchoscopy.
Donald Vinh practices practicing medicine in Vancouver, Canada. Mr. Vinh is rated as an Elite expert by MediFind in the treatment of Secondary Immunodeficiency (SID). He is also highly rated in 7 other conditions, according to our data. His clinical expertise encompasses Secondary Immunodeficiency (SID), Primary Immunodeficiency (PID), COVID-19, Severe Acute Respiratory Syndrome (SARS), and Bone Marrow Transplant.
Internal Medicine Specialties At Durham Outpatient Center
Brian Boer is an Intensive Care Medicine specialist and a Pulmonary Medicine provider practicing medicine in Omaha, Nebraska. He has been practicing medicine for over 17 years. Dr. Boer is rated as an Advanced provider by MediFind in the treatment of Secondary Immunodeficiency (SID). He is also highly rated in 9 other conditions, according to our data. His clinical expertise encompasses Squamous Cell Lung Carcinoma, Lung Adenocarcinoma, Small Cell Lung Cancer (SCLC), ALK-Positive Non-Small Cell Lung Cancer, and Gastrostomy.
Summary: Multiple myeloma is a cancer of the plasma cells in the bone marrow. The main aim of this study is to learn how well the Immune Globulin Infusion (human), 10 percentage (%) (IGI, 10%) can help prevent infections in participants with multiple myeloma receiving B-cell maturation antigen (BCMA) x cluster of differentiation 3 (CD3) directed bispecific antibody therapy. Participants will be randomly as...
Summary: In this study, multiple myeloma participants with secondary immunodeficiency (SID) will be treated with HyQvia according to their clinic's standard practice. The study's main aim is to look into infusion parameters of HyQvia administration.